Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neutropenia 1Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 508Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 328Paclitaxel 324Oxaliplatin 323Gemcitabine 320Docetaxel 310Fluorouracil 282Drug Therapy 243apatinib 242Bevacizumab 228camrelizumab 214Etoposide 200Irinotecan 175Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138Pemetrexed 136Cytarabine 136anlotinib 135toripalimab 130Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 116Radiosurgery 116

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Interventional × Maxy G34 × Clear all
NCT00501332 2007-12-24

Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

Maxygen Holdings Ltd.

Phase 2 Unknown
30 enrolled
Breast

Breast Neoplasms, Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡